Dabrafenib in pediatric patients with BRAF V600 mutation-positive high-grade glioma: Results from a phase 1/2a single-arm study.
- DOI
- 10.1093/nop/npaf061
- Published
- 2025 Dec
- Container
- Neuro-oncology practice
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1093/nop/npaf061,
title = {Dabrafenib in pediatric patients with BRAF V600 mutation-positive high-grade glioma: Results from a phase 1/2a single-arm study.},
author = {Geoerger B and Moreno L and Bouffet E and Upadhyaya SA and André N and Aerts I and Plant-Fox AS and Roughton M and Russo M and Hargrave D},
year = {2025},
journal = {Neuro-oncology practice},
doi = {10.1093/nop/npaf061},
url = {https://doi.org/10.1093/nop/npaf061}
}RIS
TY - JOUR TI - Dabrafenib in pediatric patients with BRAF V600 mutation-positive high-grade glioma: Results from a phase 1/2a single-arm study. AU - Geoerger B AU - Moreno L AU - Bouffet E AU - Upadhyaya SA AU - André N AU - Aerts I AU - Plant-Fox AS AU - Roughton M AU - Russo M AU - Hargrave D PY - 2025 JO - Neuro-oncology practice DO - 10.1093/nop/npaf061 UR - https://doi.org/10.1093/nop/npaf061 ER -
APA
B, G., L, M., E, B., SA, U., N, A., I, A., AS, P., M, R., M, R., & D, H. (2025). Dabrafenib in pediatric patients with BRAF V600 mutation-positive high-grade glioma: Results from a phase 1/2a single-arm study.. Neuro-oncology practice. https://doi.org/10.1093/nop/npaf061
Source records
- pubmed · retrieved 2026-09-25T23:23:17.797Z